Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > PCSK9(Gene name) > Human
  • Add your favorite
  • PCSK9 (Gene name),
  • Proprotein convertase subtilisin/kexin type 9 (Protein name ),  PCSK9_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    PCSK9(PSEC0052;NARC1);
    Protein name:
    Proprotein convertase subtilisin/kexin type 9;
    Alternative:
    Proprotein convertase 9(PC9);Neural apoptosis-regulated convertase 1(NARC-1);Subtilisin/kexin-like protease PC9;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    The precursor protein but not the mature protein may form multimers.
    Function:
    May be implicated in the differentiation of cortical neurons and may play a role in cholesterol homeostasis.
    Subcellular Location:
    Secreted
    Protein Attributes:
    Sequence length:
    692
    Sequence:
    50:
    MGTVSSRRSW | WPLPLLLLLL | LLLGPAGARA | QEDEDGDYEE | LVLALRSEED | 
    100:
    GLAEAPEHGT | TATFHRCAKD | PWRLPGTYVV | VLKEETHLSQ | SERTARRLQA | 
    150:
    QAARRGYLTK | ILHVFHGLLP | GFLVKMSGDL | LELALKLPHV | DYIEEDSSVF | 
    200:
    AQSIPWNLER | ITPPRYRADE | YQPPDGGSLV | EVYLLDTSIQ | SDHREIEGRV | 
    250:
    MVTDFENVPE | EDGTRFHRQA | SKCDSHGTHL | AGVVSGRDAG | VAKGASMRSL | 
    300:
    RVLNCQGKGT | VSGTLIGLEF | IRKSQLVQPV | GPLVVLLPLA | GGYSRVLNAA | 
    350:
    CQRLARAGVV | LVTAAGNFRD | DACLYSPASA | PEVITVGATN | AQDQPVTLGT | 
    400:
    LGTNFGRCVD | LFAPGEDIIG | ASSDCSTCFV | SQSGTSQAAA | HVAGIAAMML | 
    450:
    SAEPELTLAE | LRQRLIHFSA | KDVINEAWFP | EDQRVLTPNL | VAALPPSTHG | 
    500:
    AGWQLFCRTV | WSAHSGPTRM | ATAVARCAPD | EELLSCSSFS | RSGKRRGERM | 
    550:
    EAQGGKLVCR | AHNAFGGEGV | YAIARCCLLP | QANCSVHTAP | PAEASMGTRV | 
    600:
    HCHQQGHVLT | GCSSHWEVED | LGTHKPPVLR | PRGQPNQCVG | HREASIHASC | 
    650:
    CHAPGLECKV | KEHGIPAPQE | QVTVACEEGW | TLTGCSALPG | TSHVLGAYAV | 
    692:
    DNTCVVRSRD | VSTTGSTSEG | AVTAVAICCR | SRHLAQASQE | LQ
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    Pfam:
    MIM:
    UniGene:
    SMR:
    Uniprot:
     
    FOR
    ELISA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    E0307h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    E0307m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    E0307r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    U0307h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    U0307m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    U0307r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    P0307Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    P0307Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Cat.:
    P0307Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Monoclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Monoclonal Antibody for Human Proprotein convertase subtilisin/kexin type 9
    Protein for Human Proprotein convertase subtilisin/kexin type 9
    Protein for Human Proprotein convertase subtilisin/kexin type 9
    Protein for Human Proprotein convertase subtilisin/kexin type 9

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications."
      Benjannet S. , Rhainds D. , Hamelin J. , Nassoury N. , Seidah N.G.
      J. Biol. Chem.281:30561-30572(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-533;SULFATION AT TYR-38;CLEAVAGE AT ARG-218 BY FURIN AND PCSK5
    2. 2.
      "The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR."
      Nassoury N. , Blasiole D.A. , Tebon Oler A. , Benjannet S. , Hamelin J. , Poupon V. , McPherson P.S. , Attie A.D. , Prat A. , Seidah N.G.
      Traffic8:718-732(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH LDLR
    3. 3.
      "Self-association of human PCSK9 correlates with its LDLR-degrading activity."
      Fan D. , Yancey P.G. , Qiu S. , Ding L. , Weeber E.J. , Linton M.F. , Fazio S.
      Biochemistry47:1631-1639(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBUNIT
    4. 4.
      "PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1."
      Jonas M.C. , Costantini C. , Puglielli L.
      EMBO Rep.9:916-922(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH BACE1
    5. 5.
      "PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans."
      Dewpura T. , Raymond A. , Hamelin J. , Seidah N.G. , Mbikay M. , Chretien M. , Mayne J.
      FEBS J.275:3480-3493(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT SER-47 AND SER-688;IDENTIFICATION BY MASS SPECTROMETRY
    6. 6.
      "The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2."
      Poirier S. , Mayer G. , Benjannet S. , Bergeron E. , Marcinkiewicz J. , Nassoury N. , Mayer H. , Nimpf J. , Prat A. , Seidah N.G.
      J. Biol. Chem.283:2363-2372(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH VLDLR AND LRP8/APOER2
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    8. 8.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    9. 9.
      "Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation."
      Chen Y. , Wang H. , Yu L. , Yu X. , Qian Y.W. , Cao G. , Wang J.
      Biochem. Biophys. Res. Commun.415:515-518(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    10. 10.
      "A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor."
      Yamamoto T. , Lu C. , Ryan R.O.
      J. Biol. Chem.286:5464-5470(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH LDLR
    11. 11.
      "Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein."
      Du F. , Hui Y. , Zhang M. , Linton M.F. , Fazio S. , Fan D.
      J. Biol. Chem.286:43054-43061(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: DOMAIN C-TERMINAL
    12. 12.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    13. 13.
      "Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor."
      Sun H. , Samarghandi A. , Zhang N. , Yao Z. , Xiong M. , Teng B.B.
      Arterioscler. Thromb. Vasc. Biol.32:1585-1595(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH APOB
    14. 14.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    15. 15.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    16. 16.
      "The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis."
      Mousavi S.A. , Berge K.E. , Leren T.P.
      J. Intern. Med.266:507-519(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    17. 17.
      "Nucleic acid molecules derived from rat brain and programmed cell death models."
      Chiang L.W.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);VARIANTS ILE-474 AND GLU-670
    18. 18.
      "Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species."
      Ding K. , McDonough S.J. , Kullo I.J.
      PLoS ONE2:E1098-E1098(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);VARIANTS ILE-474 AND GLU-670
    19. 19.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2);VARIANT ILE-474
      tissue: Cerebellum.
      tissue: Teratocarcinoma.
    20. 20.
      SeattleSNPs variation discovery resource
      Submitted (2004-11) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS LEU-23 INS; LEU-46; VAL-53; SER-425; THR-443; ILE-474; ARG-553; PRO-619 AND GLU-670
    21. 21.
      NHLBI resequencing and genotyping service (RS&G)
      Submitted (2008-12) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS LEU-23 INS; ILE-474 AND GLU-670
    22. 22.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    23. 23.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA];VARIANTS ILE-474 AND GLU-670
    24. 24.
      "The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation."
      Seidah N.G. , Benjannet S. , Wickham L. , Marcinkiewicz J. , Jasmin S.B. , Stifani S. , Basak A. , Prat A. , Chretien M.
      Proc. Natl. Acad. Sci. U.S.A.100:928-933(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF N-TERMINUS;CHARACTERIZATION;MUTAGENESIS OF CYS-67; HIS-226 AND ASN-533
    25. 25.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: AUTOCATALYTIC CLEAVAGE SITE
    26. 26.
      "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
      Olsen J.V. , Blagoev B. , Gnad F. , Macek B. , Kumar C. , Mortensen P. , Mann M.
      Cell127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    27. 27.
      "PCSK9: a convertase that coordinates LDL catabolism."
      Horton J.D. , Cohen J.C. , Hobbs H.H.
      J. Lipid Res.50:S172-S177(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    28. 28.
      "Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition."
      Tibolla G. , Norata G.D. , Artali R. , Meneghetti F. , Catapano A.L.
      Nutr. Metab. Cardiovasc. Dis.21:835-843(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    29. 29.
      "Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease."
      Abifadel M. , Rabes J.P. , Devillers M. , Munnich A. , Erlich D. , Junien C. , Varret M. , Boileau C.
      Hum. Mutat.30:520-529(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    30. 30.
      "Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients."
      Slimani A. , Jelassi A. , Jguirim I. , Najah M. , Rebhi L. , Omezzine A. , Maatouk F. , Hamda K.B. , Kacem M. , Rabes J.P. , Abifadel M. , Boileau C. , Rouis M. , Slimane M.N. , Varret M.
      Atherosclerosis222:158-166(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN LDLCQ1;VARIANT SER-174
    31. 31.
      "Regulation of epithelial sodium channel trafficking by proprotein convertase subtilisin/kexin type 9 (PCSK9)."
      Sharotri V. , Collier D.M. , Olson D.R. , Zhou R. , Snyder P.M.
      J. Biol. Chem.287:19266-19274(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH SCNN1A; SCNN1B AND SCNN1G
    32. 32.
      "The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol."
      Piper D.E. , Jackson S. , Liu Q. , Romanow W.G. , Shetterly S. , Thibault S.T. , Shan B. , Walker N.P.
      Structure15:545-552(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 31-692
    33. 33.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HCHOLA3 ARG-127 AND LEU-216;VARIANTS LEU-46; VAL-53 AND GLU-670
    34. 34.
      "A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol."
      Kotowski I.K. , Pertsemlidis A. , Luke A. , Cooper R.S. , Vega G.L. , Cohen J.C. , Hobbs H.H.
      Am. J. Hum. Genet.78:410-422(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS LEU-46; VAL-53; LYS-57; TRP-237; PHE-253; ASN-391; GLN-417; SER-425; THR-443; TRP-469; ILE-474; GLY-482; LEU-515; ARG-553; GLU-554; PRO-619 AND GLU-670
    35. 35.
      "The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene."
      Abifadel M. , Rabes J.-P. , Jambart S. , Halaby G. , Gannage-Yared M.-H. , Sarkis A. , Beaino G. , Varret M. , Salem N. , Corbani S. , Aydenian H. , Junien C. , Munnich A. , Boileau C.
      Hum. Mutat.30:E682-E691(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN LDLCQ1;VARIANT LEU-23 INS;IMPACT ON FAMILIAL HYPERCHOLESTEROLEMIA
    36. 36.
      "Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels."
      Huijgen R. , Sjouke B. , Vis K. , de Randamie J.S. , Defesche J.C. , Kastelein J.J. , Hovingh G.K. , Fouchier S.W.
      Hum. Mutat.33:448-455(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN LDLCQ1;VARIANTS LEU-23 INS; LEU-46; VAL-53; SER-394; ILE-474 AND GLU-670
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter